Multiple sclerosis findings in the spinal cord

References

• Ramirez-Lassepas M, Tulloch JW, Quinones MR, Snyder BD. Acute radicular pain as a presenting symptom in multiple sclerosis. Arch. Neurol.49(3), 255–258 (1992).
   PubMedGoogle Scholar
• Kraus JA, Stuper BK, Berlit P. Multiple sclerosis presenting with a Brown–Sequard syndrome. J. Neurol. Sci.156(1), 112–113 (1998).
   PubMedGoogle Scholar
• Ozaki I, Suzuki C, Baba M, Matsunaga M. Multiple sclerosis manifesting as a Brown–Sequard syndrome. Eur. J. Neurol.10(2), 190–191 (2003).
   PubMedGoogle Scholar
• Sotgiu S, Sechi G, Pugliatti M et al. Multiple sclerosis associated with syringomyelia. J. Neurol. Neurosurg. Psychiatr.67(2), 248 (1999).
   PubMedGoogle Scholar
• Iwasaki Y, Ikeda K, Ichikawa Y, Igarashi O. Multiple sclerosis and syrinx formation. Acta Neurol. Scand.101(5), 346 (2000).
   PubMedGoogle Scholar
• Matsuda M, Tabata K, Miki J et al. Multiple sclerosis with secondary syringomyelia. An autopsy report. J. Neurol. Sci.184(2), 189–196 (2001).
   PubMedGoogle Scholar
• Ransohoff RM, Whitman GJ, Weinstein MA. Noncommunicating syringomyelia in multiple sclerosis: detection by magnetic resonance imaging. Neurology40(4), 718–721 (1990).
   PubMedGoogle Scholar
• Solaro C, Uccelli A, Gentile R et al. Multiple sclerosis and non-communicating syringomyelia: a casual association or linked diseases? Acta Neurol. Scand.100(4), 270–273 (1999).
   PubMedGoogle Scholar
• Waziri A, Vonsattel JP, Kaiser MG, Anderson RC. Expansile, enhancing cervical cord lesion with an associated syrinx secondary to demyelination. Case report and review of the literature. J. Neurosurg.6(1), 52–56 (2007).
   Google Scholar
• Trop I, Bourgouin PM, Lapierre Y et al. Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activity. AJNR Am. J. Neuroradiol.19(6), 1025–1033 (1998).
   PubMed Web of Science ®Google Scholar
• Thorpe JW, Kidd D, Moseley IF et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology46(2), 373–378 (1996).
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann. Neurol.58(6), 840–846 (2005).
   PubMed Web of Science ®Google Scholar
• Bot JC, Barkhof F, Polman CH et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology62(2), 226–233 (2004).
   PubMed Web of Science ®Google Scholar
• Thorpe JW, Kidd D, Moseley IF et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain119(Pt 3), 709–714 (1996).
   PubMed Web of Science ®Google Scholar
• Bot JC, Barkhof F, Lycklama a Nijeholt G et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology223(1), 46–56 (2002).
   PubMed Web of Science ®Google Scholar
• Brex PA, Leary SM, O’Riordan JI et al. Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis. J. Neurol. Neurosurg. Psychiatr.70(4), 544–547 (2001).
   PubMed Web of Science ®Google Scholar
• Dalton CM, Brex PA, Miszkiel KA et al. Spinal cord MRI in clinically isolated optic neuritis. J. Neurol. Neurosurg. Psychiatr.74(11), 1577–1580 (2003).
   PubMedGoogle Scholar
• Cordonnier C, de Seze J, Breteau G et al. Prospective study of patients presenting with acute partial transverse myelopathy. J. Neurol.250(12), 1447–1452 (2003).
   PubMedGoogle Scholar
• Steiner I, Feir G, Soffer D, Pleet AB, Abramsky O. Chronic progressive myelopathy: its relation to the spinal progressive form of multiple sclerosis. Acta Neurol. Scand.77(2), 152–157 (1988).
   PubMedGoogle Scholar
• Jeffery DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch. Neurol.50(5), 532–535 (1993).
   PubMedGoogle Scholar
• de Seze J, Stojkovic T, Gauvrit JY et al. Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates. J. Neurol.248(4), 297–303 (2001).
   PubMed Web of Science ®Google Scholar
• Vaithianathar L, Tench CR, Morgan PS, Constantinescu CS. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis – a quantitative T1 relaxation time mapping approach. J. Neurol.250(3), 307–315 (2003).
   PubMedGoogle Scholar
• Ukkonen M, Dastidar P, Heinonen T, Laasonen E, Elovaara I. Volumetric quantitation by MRI in primary progressive multiple sclerosis: volumes of plaques and atrophy correlated with neurological disability. Eur. J. Neurol.10(6), 663–669 (2003).
   PubMedGoogle Scholar
• Tartaglino LM, Friedman DP, Flanders AE et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology195(3), 725–732 (1995).
   PubMed Web of Science ®Google Scholar
• Kidd D, Thorpe JW, Thompson AJ et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology43(12), 2632–2637 (1993).
   PubMed Web of Science ®Google Scholar
• Rot U, Mesec A. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis. Clin. Neurol. Neurosurg.108(3), 271–274 (2006).
   Google Scholar
• Lin X, Blumhardt LD, Constantinescu CS. The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study. Acta Neurol. Scand.108(6), 401–406 (2003).
   PubMed Web of Science ®Google Scholar
• Mann R, Constantinescu C, Tench C. Upper cervical spinal cord cross sectional area in relapsing remitting multiple sclerosis: application of a new technique for measuring cross sectional area on magnetic resonance images. J. Magn. Reson. Imaging26(1), 61–65 (2007).
   PubMedGoogle Scholar
• Rashid W, Davies GR, Chard DT et al. Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size. J. Magn. Reson. Imaging23(4), 473–476 (2006).
   PubMedGoogle Scholar
• Bieniek M, Altmann DR, Davies GR et al. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatr.77(9), 1036–1039 (2006).
   PubMed Web of Science ®Google Scholar
• Stevenson VL, Leary SM, Losseff NA et al. Spinal cord atrophy and disability in MS: a longitudinal study. Neurology51(1), 234–238 (1998).
   PubMed Web of Science ®Google Scholar
• Lin X, Tench CR, Turner B, Blumhardt LD, Constantinescu CS. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon-β-1a (Rebif) treatment trial. J. Neurol. Neurosurg. Psychiatr.74(8), 1090–1094 (2003).
   PubMed Web of Science ®Google Scholar
• Rashid W, Davies GR, Chard DT et al. Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J. Neurol. Neurosurg. Psychiatr.77(1), 51–55 (2006).
   PubMed Web of Science ®Google Scholar
• Lycklama a Nijeholt GJ, Barkhof F, Scheltens P et al. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. AJNR Am. J. Neuroradiol.18(6), 1041–1048 (1997).
   PubMedGoogle Scholar
• Losseff NA, Webb SL, O’Riordan JI et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain119(Pt 3), 701–708 (1996).
   PubMed Web of Science ®Google Scholar
• Edwards SG, Gong QY, Liu C et al. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain122(Pt 2), 291–301 (1999).
   PubMed Web of Science ®Google Scholar
• Rovaris M, Bozzali M, Santuccio G et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain124(Pt 12), 2540–2549 (2001).
   PubMedGoogle Scholar
• Kidd D, Thorpe JW, Kendall BE et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiatr.60(1), 15–19 (1996).
   PubMedGoogle Scholar
• Stevenson VL, Miller DH, Leary SM et al. One year follow up study of primary and transitional progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiatr.68(6), 713–718 (2000).
   PubMedGoogle Scholar
• Ingle GT, Stevenson VL, Miller DH, Thompson AJ. Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain126(Pt 11), 2528–2536 (2003).
   PubMed Web of Science ®Google Scholar
• Filippi M, Bozzali M. A conventional and magnetization transfer MRI study of the cervial cord in patients with MS. Neurology54(1), 207–213 (2000).
   PubMed Web of Science ®Google Scholar
• Lycklama a Nijeholt GJ, Castelijns JA. Magnetization transfer ratio of the spinal cord in multiple sclerosis: relationship to atrophy and neurologic disability. J. Neuroimaging10(2), 67–72 (2000).
   PubMed Web of Science ®Google Scholar
• Liu C, Edwards S, Gong Q, Roberts N, Blumhardt LD. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr.66(3), 323–330 (1999).
   PubMed Web of Science ®Google Scholar
• Bot JC, Blezer EL, Kamphorst W et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology233(2), 531–540 (2004).
   PubMed Web of Science ®Google Scholar
• Bashir K, Whitaker JN. Clinical and laboratory features of primary progressive and secondary progressive MS. Neurology53(4), 765–771 (1999).
   PubMedGoogle Scholar
• Tench CR, Morgan PS, Jaspan T, Auer DP, Constantinescu CS. Spinal cord imaging in multiple sclerosis. J. Neuroimaging15(Suppl. 4), S94–S102 (2005).
   Google Scholar
• Lin X, Tench CR, Evangelou N, Jaspan T, Constantinescu CS. Measurement of spinal cord atrophy in multiple sclerosis. J. Neuroimaging14(Suppl. 3), S20–S26 (2004).
   Google Scholar
• Rocca MA, Hickman SJ, Bo L et al. Imaging spinal cord damage in multiple sclerosis. J. Neuroimaging15(4), 297–304 (2005).
   PubMedGoogle Scholar
• Lycklama G, Thompson A, Filippi M et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol.2(9), 555–562 (2003).
   PubMed Web of Science ®Google Scholar
• Silver NC, Good CD, Sormani MP et al. A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis. J. Neurol.248(3), 215–224 (2001).
   PubMed Web of Science ®Google Scholar
• Rocca MA, Mastronardo G, Horsfield MA et al. Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. AJNR Am. J. Neuroradiol.20(9), 1710–1716 (1999).
   PubMed Web of Science ®Google Scholar
• Hittmair K, Mallek R, Prayer D, Schindler EG, Kollegger H. Spinal cord lesions in patients with multiple sclerosis: comparison of MR pulse sequences. AJNR Am. J. Neuroradiol.17(8), 1555–1565 (1996).
   PubMed Web of Science ®Google Scholar
• Tench CR, Morgan PS, Constantinescu CS. Measurement of cervical spinal cord cross-sectional area by MRI using edge detection and partial volume correction. J. Magn. Reson. Imaging21(3), 197–203 (2005).
   PubMedGoogle Scholar
• Leary SM, Miller DH, Stevenson VL et al. Interferon-β-1a in primary progressive MS: an exploratory, randomized, controlled trial. Neurology60(1), 44–51 (2003).
   PubMed Web of Science ®Google Scholar
• Weinshenker BG. Neuromyelitis optica is distinct from multiple sclerosis. Arch. Neurol.64(6), 899–901 (2007).
   PubMedGoogle Scholar
• Roach ES. Is neuromyelitis optica a distinct entity? Arch. Neurol.64(6), 906 (2007).
   PubMedGoogle Scholar
• Frohman EM, Kerr D. Is neuromyelitis optica distinct from multiple sclerosis?: something for “lumpers” and “splitters”. Arch. Neurol.64(6), 903–905 (2007).
   PubMedGoogle Scholar
• Galetta SL, Bennett J. Neuromyelitis optica is a variant of multiple sclerosis. Arch. Neurol.64(6), 901–903 (2007).
   PubMedGoogle Scholar
• Filippi M, Rocca MA, Moiola L et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica. Neurology53(8), 1705–1710 (1999).
   PubMed Web of Science ®Google Scholar
• Minagar A, Alexander JS, Fowler MR, Long AC, Kelley RE. Devic disease: clinical course, pathophysiology, and management. Pathophysiology9(1), 33 (2002).
   PubMedGoogle Scholar
• de Seze J, Stojkovic T, Ferriby D et al. Devic’s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J. Neurol. Sci.197(1–2), 57–61 (2002).
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology68(8), 603–605 (2007).
   PubMed Web of Science ®Google Scholar
• Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic’s neuromyelitis optica: a clinicopathological study of 8 patients. Ann. Neurol.34(2), 162–168 (1993).
   PubMed Web of Science ®Google Scholar
• Lucchinetti CF, Mandler RN, McGavern D et al. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain125(Pt 7), 1450–1461 (2002).
   PubMed Web of Science ®Google Scholar
• Misu T, Fujihara K, Kakita A et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain130(Pt 5), 1224–1234 (2007).
   PubMed Web of Science ®Google Scholar
• Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol.2(2), 117–127 (2003).
   PubMed Web of Science ®Google Scholar
• Weinshenker BG, Wingerchuk DM, Nakashima I, Fujihara K, Lennon VA. OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol.5(2), 110–111 (2006).
   PubMedGoogle Scholar
• Fukazawa T, Tashiro K, Hamada T et al. Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern. Med.31(3), 349–352 (1992).
   PubMedGoogle Scholar
• Fukazawa T, Kikuchi S, Miyagishi R et al. CSF pleocytosis and expansion of spinal lesions in Japanese multiple sclerosis with special reference to the new diagnostic criteria. J. Neurol.252(7), 824–829 (2005).
   PubMed Web of Science ®Google Scholar
• Kira J, Kanai T, Nishimura Y et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann. Neurol.40(4), 569–574 (1996).
   PubMed Web of Science ®Google Scholar
• Misu T, Fujihara K, Nakashima I et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain125(Pt 11), 2460–2468 (2002).
   PubMed Web of Science ®Google Scholar
• Warabi Y, Matsumoto Y, Hayashi H. Interferon-β-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J. Neurol. Sci.252(1), 57–61 (2007).
   PubMed Web of Science ®Google Scholar
• Weinstock-Guttman B, Ramanathan M, Lincoff N et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch. Neurol.63(7), 957–963 (2006).
   PubMedGoogle Scholar
• Cree BA, Lamb S, Morgan K et al. An open label study of the effects of rituximab in neuromyelitis optica. Neurology64(7), 1270–1272 (2005).
   PubMed Web of Science ®Google Scholar
• Nakashima I, Fujihara K, Miyazawa I et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J. Neurol. Neurosurg. Psychiatr.77(9), 1073–1075 (2006).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Fujihara K, Nakashima I et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain130(Pt 5), 1235–1243 (2007).
   PubMed Web of Science ®Google Scholar
• Roemer SF, Parisi JE, Lennon VA et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain130(Pt 5), 1194–1205 (2007).
   PubMed Web of Science ®Google Scholar
• Matsuoka T, Matsushita T, Kawano Y et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain130(Pt 5), 1206–1223 (2007).
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology66(10), 1485–1489 (2006).
   PubMed Web of Science ®Google Scholar
• Oppenheimer DR. The cervical cord in multiple sclerosis. Neuropathol. Appl. Neurobiol.4(2), 151–162 (1978).
   PubMedGoogle Scholar
• Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol.48(6), 893–901 (2000).
   PubMed Web of Science ®Google Scholar
• DeLuca GC, Williams K, Evangelou N, Ebers GC, Esiri MM. The contribution of demyelination to axonal loss in multiple sclerosis. Brain129(Pt 6), 1507–1516 (2006).
   PubMedGoogle Scholar
• DeLuca GC, Ebers GC, Esiri MM. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain127(Pt 5), 1009–1018 (2004).
   PubMedGoogle Scholar
• Gilmore CP, Bo L, Owens T et al. Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology. Brain Pathol.16(3), 202–208 (2006).
   PubMed Web of Science ®Google Scholar
• Gilmore CP, DeLuca GC, Bo L et al. Spinal cord atrophy in multiple sclerosis caused by white matter volume loss. Arch. Neurol.62(12), 1859–1862 (2005).
   PubMedGoogle Scholar
• Ganter P, Prince C, Esiri MM. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol. Appl. Neurobiol.25(6), 459–467 (1999).
   PubMed Web of Science ®Google Scholar
• Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain123(Pt 2), 308–317 (2000).
   PubMed Web of Science ®Google Scholar
• Evangelou N, DeLuca GC, Owens T, Esiri MM. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain128(Pt 1), 29–34 (2005).
   PubMed Web of Science ®Google Scholar
• Nijeholt GJ, Bergers E, Kamphorst W et al. Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain124(Pt 1), 154–166 (2001).
   PubMedGoogle Scholar